K. Fox i wsp. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ... in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ... in patients with stable coronary artery disease without clinical heart failure , LINK: Am Heart J 2013;0:1-8.e6. W grupie leków wpływających korzystnie na redukcję ryzyka...